ArticleCancers2024

Phase I/II Trial of Urokinase Plasminogen Activator-Targeted Oncolytic Newcastle Disease Virus for Canine Intracranial Tumors.

John H Rossmeisl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.